Annual Cash & Cash Equivalents
$446.60 K
-$6.06 M-93.14%
December 31, 2022
Summary
- As of February 25, 2025, CMRA annual cash & cash equivalents is $446.60 thousand, with the most recent change of -$6.06 million (-93.14%) on December 31, 2022.
- During the last 3 years, CMRA annual cash & cash equivalents has risen by +$291.20 thousand (+187.39%).
- CMRA annual cash & cash equivalents is now -93.14% below its all-time high of $6.51 million, reached on December 31, 2021.
Performance
CMRA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$1.77 M
+$1.29 M+271.17%
September 30, 2023
Summary
- As of February 25, 2025, CMRA quarterly cash and cash equivalents is $1.77 million, with the most recent change of +$1.29 million (+271.17%) on September 30, 2023.
- Over the past year, CMRA quarterly cash and cash equivalents has stayed the same.
- CMRA quarterly cash and cash equivalents is now -72.84% below its all-time high of $6.51 million, reached on December 1, 2021.
Performance
CMRA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CMRA Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -93.1% | 0.0% |
| 3 y3 years | +187.4% | 0.0% |
| 5 y5 years | +187.4% | 0.0% |
CMRA Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -93.1% | at low | -72.8% | +295.9% |
| 5 y | 5-year | -93.1% | +187.4% | -72.8% | +295.9% |
| alltime | all time | -93.1% | +187.4% | -72.8% | +295.9% |
Comera Life Sciences Holdings Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $1.77 M(+271.2%) |
| Jun 2023 | - | $476.30 K(-69.0%) |
| Mar 2023 | - | $1.54 M(+244.5%) |
| Dec 2022 | $446.60 K | $446.60 K(-83.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $2.67 M(-46.0%) |
| Jun 2022 | - | $4.94 M(-24.1%) |
| Dec 2021 | $6.51 M(+4089.3%) | - |
| Dec 2021 | - | $6.51 M |
| Dec 2020 | $155.40 K | - |
FAQ
- What is Comera Life Sciences Holdings annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Comera Life Sciences Holdings?
- What is Comera Life Sciences Holdings annual cash & cash equivalents year-on-year change?
- What is Comera Life Sciences Holdings quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Comera Life Sciences Holdings?
- What is Comera Life Sciences Holdings quarterly cash and cash equivalents year-on-year change?
What is Comera Life Sciences Holdings annual cash & cash equivalents?
The current annual cash & cash equivalents of CMRA is $446.60 K
What is the all time high annual cash & cash equivalents for Comera Life Sciences Holdings?
Comera Life Sciences Holdings all-time high annual cash & cash equivalents is $6.51 M
What is Comera Life Sciences Holdings annual cash & cash equivalents year-on-year change?
Over the past year, CMRA annual cash & cash equivalents has changed by -$6.06 M (-93.14%)
What is Comera Life Sciences Holdings quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CMRA is $1.77 M
What is the all time high quarterly cash and cash equivalents for Comera Life Sciences Holdings?
Comera Life Sciences Holdings all-time high quarterly cash and cash equivalents is $6.51 M
What is Comera Life Sciences Holdings quarterly cash and cash equivalents year-on-year change?
Over the past year, CMRA quarterly cash and cash equivalents has changed by $0.00 (0.00%)